Discover

ACON
Aclarion, Inc.
2.34
2 x 1.78
2 x 3.14
bid
ask
+
0.03
1.30%
2 @ 04:00 PM
2.32 -0.02 (0.85%)
Ytd-49.13%
1y-72.24%
2.33
day range
2.37
2.02
52 week range
9.69
Open2.35Prev Close2.31Low2.33High2.37Mkt Cap6.74M
Vol7.30KAvg Vol52.45KEPS-7.48P/EN/AForward P/E-0.24
Beta0.40Short Ratio0.77Inst. Own3.57%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg2.46200-d Avg3.121yr Est1.30

ACON News

Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment
prismmediawire.com
Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment

PR Audio: BROOMFIELD, Colo., October 8, 2026 – PRISM MediaWire (Press Release Service – Press Releas

Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment
globenewswire.com
Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment

New criteria fully approved at nine of eleven active sites expected to significantly accelerate enro

Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
prismmediawire.com
Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites

PR Audio: BROOMFIELD, Colo., September 29, 2026 – PRISM MediaWire (Press Release Service – Press Rel

Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
globenewswire.com
Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites

NYU Langone Health is a nationally recognized academic medical center with deep expertise in spine s

Aclarion, Inc. (NASDAQ:ACON) Short Interest Update
defenseworld.net
Aclarion, Inc. (NASDAQ:ACON) Short Interest Update

Aclarion, Inc. (NASDAQ: ACON - Get Free Report) was the target of a significant increase in short in

12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers Profusa (NASDAQ:PFSA) stock increased by 112.5% to $4.36 during Thursday's pre-market s

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 90.6% to $3.87 during Wednesday's after

Reviewing OptimizeRx (NASDAQ:OPRX) & Aclarion (NASDAQ:ACON)
defenseworld.net
Reviewing OptimizeRx (NASDAQ:OPRX) & Aclarion (NASDAQ:ACON)

OptimizeRx (NASDAQ: OPRX - Get Free Report) and Aclarion (NASDAQ: ACON - Get Free Report) are both s

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Tempest Therapeutics (NASDAQ:TPST) stock increased by 41.6% to $1.07 during Tuesday's a

Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site
prismmediawire.com
Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial

PR Audio: BROOMFIELD, Colo., August 20, 2026 – PRISM MediaWire (Press Release Service – Press Releas

benzinga.com
Aclarion Announces University Of Arizona College Of Medicine - Phoenix As New Clinical Site In Its C

University of Arizona College of Medicine – Phoenix is home to a leading neurosurgery and orthopedic

Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site
globenewswire.com
Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial

University of Arizona College of Medicine – Phoenix is home to a leading neurosurgery and orthopedic

benzinga.com
Aclarion Says USPTO Issues Notice Of Allowance For U.S. Patent Application Titled Multi-Voxel Prescr

Patent protects the precision of MRS data capture within the target disc — a critical step in the No

Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process
prismmediawire.com
Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Sp

BROOMFIELD, Colo., August 12, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribu

Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process
globenewswire.com
Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Sp

Patent protects the precision of MRS data capture within the target disc — a critical step in the No

Aclarion, Inc. (ACON) Reports Q2 Loss, Lags Revenue Estimates
zacks.com
Aclarion, Inc. (ACON) Reports Q2 Loss, Lags Revenue Estimates

Aclarion, Inc. (ACON) came out with a quarterly loss of $1.12 per share versus the Zacks Consensus E

Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology
prismmediawire.com
Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincen

PR Audio: BROOMFIELD, Colo., August 04, 2026 – PRISM MediaWire (Press Release Service – Press Releas

Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology
globenewswire.com
Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincen

Partnership brings Nociscan for chronic low back pain to one of the nation's leading neurosurgery an

Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026
prismmediawire.com
Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026

PR Audio: Broomfield, CO, July 29, 2026 – PRISM MediaWire (Press Release Service – Press Release Dis

Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026
globenewswire.com
Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026

141% year-over-year scan volume growth in first half of 2026 Reimbursement momentum in the U.K. tran

Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan's Growing Role in Real-World Clinical Practice
prismmediawire.com
Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan's Growing Role in Real-World

PR Audio: BROOMFIELD, Colo., July 21, 2026 – PRISM MediaWire (Press Release Service – Press Release

Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan's Growing Role in Real-World Clinical Practice
globenewswire.com
Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan's Growing Role in Real-World

Abstracts presented at American Society of Pain & Neuroscience (ASPN) annual meeting across surgical

benzinga.com
Aclarion Announces Texas Spine Care Center As New Clinical Site In Chronic Low bAck pain Randomized

Texas Spine Care Center is a high-volume orthopedic spine practice with a philosophy of understandin

Aclarion Announces Texas Spine Care Center as New CLARITY Site
prismmediawire.com
Aclarion Announces Texas Spine Care Center as New CLARITY Site

PR Audio: BROOMFIELD, Colo., July 07, 2026 – PRISM MediaWire (Press Release Service – Press Release

Aclarion Announces Texas Spine Care Center as New CLARITY Site
globenewswire.com
Aclarion Announces Texas Spine Care Center as New CLARITY Site

Texas Spine Care Center is a high-volume orthopedic spine practice with a philosophy of understandin

Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub
globenewswire.com
Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub

BROOMFIELD, Colo., June 10, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (

benzinga.com
Aclarion Launches Market Access Program In Partnership With PRIA Healthcare

Partnership supports reimbursement strategy and U.S. commercial expansion for Aclarion's AI-driv

benzinga.com
Aclarion Board Reviews Echo Lake's Unsolicited Public Proposal And Unanimously Determined To Reject

Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-st

benzinga.com
Aclarion Partners With Institute of Neuro Innovation on Back Pain Technology

Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-st

benzinga.com
Aclarion Announces That Its Nociscan Technology Was Used In A New Research Study Exploring The Biolo

Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW))), a commercial-s

SentinelOne To Rally Nearly 40%? Here Are 10 Analyst Forecasts For Friday
benzinga.com
SentinelOne To Rally Nearly 40%? Here Are 10 Analyst Forecasts For Friday

Top Wall Street analysts changed outlook on top names. For full changes, see analyst ratings page. S

benzinga.com
Ascendiant Capital Maintains Buy on Aclarion, Raises Price Target to $7.5

Ascendiant Capital analyst Lucas Ward maintains Aclarion (NASDAQ:ACON) with a Buy and raises the

benzinga.com
Echo Lake Capital Offers To Acquire Aclarion At $4.00/Share And Contingent Value Right Representing

Offers $4.00 per share in cash plus CVRStock currently trades below the value of its cash and other

benzinga.com
Aclarion Q1 EPS $(1.34) Beats $(1.55) Estimate, Sales $21.140K Miss $25.000K Estimate

Aclarion (NASDAQ:ACON) reported quarterly losses of $(1.34) per share which beat the analyst consens

benzinga.com
Aclarion Adds Lanman Spinal Neurosurgery As Clinical Site In CLARITY Trial

Lanman Spinal Neurosurgery is a leading spine-focused private practice recognized for its expertise

benzinga.com
Aclarion Establishes Second Commercial Agreement With Weill Cornell Medicine; Deal Brings Nociscan T

Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-st

benzinga.com
Aclarion Announces $2.5M Buyback Plan

Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-st

benzinga.com
Aclarion Secures U.S. Patent Covering Machine Learning–Based Platform For Analyzing Magnetic Resonan

Patent covers use of AI in workflows of future products to accelerate company's ability to scale

benzinga.com
Aclarion Signs Commercial Agreement With Weill Cornell Medicine Over Access For Nociscan To Weill Co

Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-st

benzinga.com
Ascendiant Capital Maintains Buy on Aclarion, Lowers Price Target to $7

Ascendiant Capital analyst Lucas Ward maintains Aclarion (NASDAQ:ACON) with a Buy and lowers the

benzinga.com
Aclarion Adopts 1-Year Shareholder Rights Plan To Protect Long-Term Value And Prevent Hostile Takeov

Aclarion, Inc. (NASDAQ:ACON, ACONW))) ("Aclarion" or the "Company") today announced

benzinga.com
Aclarion Expands AI Tool To Help Doctors Pinpoint Back Pain, Eyes Growth As More Hospitals Adopt Noc

Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW))), a commercial-s

benzinga.com
Aclarion Expands Nociscan Availability In Los Angeles, Partners With Source Healthcare To Support Gr

Expands availability of Nociscan in the greater Los Angeles areaReinforces Nociscan's non-invasi

Aclarion Raises $10.4 Million, Sharpens Focus On Nociscan Rollout
benzinga.com
Aclarion Raises $10.4 Million, Sharpens Focus On Nociscan Rollout

Aclarion, Inc. (NASDAQ: ACON) closed a $10.4 million financing at $5.18/share, boosting balance shee

benzinga.com
Aclarion Raises $10.4M, Extends Cash Runway Into 2028

Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-st

Is the Market Bullish or Bearish on Aclarion Inc?
benzinga.com
Is the Market Bullish or Bearish on Aclarion Inc?

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

Dow Edges Higher; US Economy Adds 50,000 Jobs In December
benzinga.com
Dow Edges Higher; US Economy Adds 50,000 Jobs In December

WD-40 Posts Downbeat Q1 Results, Joins Olin, AXT And Other Big Stocks Moving Lower In Friday's Pre-Market Session
benzinga.com
WD-40 Posts Downbeat Q1 Results, Joins Olin, AXT And Other Big Stocks Moving Lower In Friday's Pre-M

Why Tilray Brands Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Tilray Brands Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket